19
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hypoglycemic and hypolipidemic activity of Ficus mollis leaves

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The present research was designed to evaluate the hypoglycemic and hypolipidemic activity of ethyl acetate extract of Ficus mollis Vahl, Moraceae, against dexamethasone induced insulin resistance. Wistar albino rats were treated with dexamethasone (10 mg/kg) for ten days to induce insulin sensitivity. Hypoglycemic and hypolipidemic activity of ethyl acetate extract of F. mollis were evaluated by using two different doses (200 and 400 mg/kg body weight p.o.). The day 11 all rats were sacrificed and serum was collected for biochemical estimation, liver and pancreas were excised for histopathology. Administration of dexamethasone shows hyperglycemia and hyperlipidemia due to insulin resistance. Ethyl acetate extract of F. mollis reverted the hyperglycemia and hyperlipidemia caused by dexamethasone in a dose dependent manner. The changes were further confirmed by histopathological report. The extract effect was compared with reference standard glibenclamide, which shows a similar effect. From these findings it has been concluded that the ethyl acetate extract of Ficus mollis offered significant protection against dexamethasone induced hyperglycemia and hyperlipidemia.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          Phytochemical methods A guide to modern technique of plant analysis

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.

            The thiazolidinedione BRL 49653 and the thiazolidinedione derivative CGP 52608 are lead compounds of two pharmacologically different classes of compounds. BRL 49653 is a high affinity ligand of peroxisome proliferator-activated receptor gamma (PPARgamma) and a prototype of novel antidiabetic agents, whereas CGP 52608 activates retinoic acid receptor-related orphan receptor alpha (RORA) and exhibits potent antiarthritic activity. Both receptors belong to the superfamily of nuclear receptors and are structurally related transcription factors. We tested BRL 49653 and CGP 52608 for receptor specificity on PPARgamma, RORA, and retinoic acid receptor alpha, a closely related receptor to RORA, and compared their pharmacological properties in in vitro and in vivo models in which these compounds have shown typical effects. BRL 49653 specifically induced PPARgamma-mediated gene activation, whereas CGP 52608 specifically activated RORA in transiently transfected cells. Both compounds were active in nanomolar concentrations. Leptin production in differentiated adipocytes was inhibited by nanomolar concentrations of BRL 49653 but not by CGP 52608. BRL 49653 antagonized weight loss, elevated blood glucose levels, and elevated plasma triglyceride levels in an in vivo model of glucocorticoid-induced insulin resistance in rats, whereas CGP 52608 exhibited steroid-like effects on triglyceride levels and body weight in this model. In contrast, potent antiarthritic activity in rat adjuvant arthritis was shown for CGP 52608, whereas BRL 49653 was nearly inactive. Our results support the concept that transcriptional control mechanisms via the nuclear receptors PPARgamma and RORA are responsible at least in part for the different pharmacological properties of BRL 49653 and CGP 52608. Both compounds are prototypes of interesting novel therapeutic agents for the treatment of non-insulin-dependent diabetes mellitus and rheumatoid arthritis.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              The role of insulin resistance in human disease

              GM Reaven (1988)
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Journal
                rbfar
                Revista Brasileira de Farmacognosia
                Rev. bras. farmacogn.
                Sociedade Brasileira de Farmacognosia (Curitiba )
                1981-528X
                August 2013
                : 23
                : 4
                : 687-691
                Affiliations
                [1 ] Annamacharya College Of Pharmacy India
                [2 ] Annamacharya College Of Pharmacy India
                Article
                S0102-695X2013000400017
                10.1590/S0102-695X2013005000056
                97301e93-853b-4497-9938-a26dc22af436

                http://creativecommons.org/licenses/by/4.0/

                History
                Product

                SciELO Brazil

                Self URI (journal page): http://www.scielo.br/scielo.php?script=sci_serial&pid=0102-695X&lng=en
                Categories
                PHARMACOLOGY & PHARMACY

                Pharmacology & Pharmaceutical medicine
                antidiabetic,antilipidemic,Ficus mollis,herbal medicine
                Pharmacology & Pharmaceutical medicine
                antidiabetic, antilipidemic, Ficus mollis, herbal medicine

                Comments

                Comment on this article